The Medication Access and Training Expansion (MATE) Act is part of a federal law passed in December 2022 that creates a new, one-time requirement for any Drug Enforcement Administration (DEA) registered practitioner. This requirement is separate from the FL Board of Medicine requirement and, while activities approved by the FL Board of Medicine for the Controlled Substances Requirement meet the DEA MATE Act needs, the reverse is not true. You can review our DEA MATE Act Frequently Asked Questions article for details on this requirement.

Meets DEA MATE Act Requirements

Nicklaus Children's Hospital may offer activities that meet the new DEA requirement as part of its CME curriculum. Activities that meet this requirement will note this in the Accreditation Statement and include the icon shown to the right. The following activities and courses contain lectures/topics that are compliant with the DEA Medication Access & Training Expansion (MATE) Act.

Grand Rounds - 04/12/2024 - Who's Next: Case Studies in Pediatric Pain

1. Review 3 case studies focused on the real world challenges of pediatric pain treatment, 2. Examine the non pharmacologic challenges in pediatric pain management, 3. Integrate Florida State Regulations regarding prescribing controlled substances into pediatric pain treatment.

Please login or register to take this course.
  • 1.00 AMA PRA Category 1 Credit™
    Nicklaus Children's Hospital designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    • 1.00 MATE Act Compliant
  • 1.00 Attendance
    Acknowledging attendance at this educational activity.
    • 1.00 Approved for AMA PRA Category 1 Credit™
One-Million Deaths and Counting: The Role of the Pediatric Workforce in Addressing the Nation's Overdose Crisis
Virtual Grand Rounds
After this Virtual Grand Round, participants should be able to: 1. Describe the epidemiology of substance use-related harm in the US, with a focus on adolescents and young adults (“youth”), 2. Prescribe opioids in a manner that reduces the likelihood of risk for long-term opioid use and addiction, and 3. Ensure evidence-based screening and treatment for youth with substance use disorders [Recorded 11/10/2023]

Grand Rounds - 11/10/2023 - One-Million Deaths and Counting...

1. Describe the epidemiology of substance use-related harm in the US, with a focus on adolescents and young adults (“youth”), 2. Prescribe opioids in a manner that reduces the likelihood of risk for long-term opioid use and addiction, 3. Ensure evidence-based screening and treatment for youth with substance use disorders

Please login or register to take this course.
  • 1.00 AMA PRA Category 1 Credit™
    Nicklaus Children's Hospital designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    • 1.00 MATE Act Compliant
  • 1.00 Attendance
    Acknowledging attendance at this educational activity.
    • 1.00 Approved for AMA PRA Category 1 Credit™
Pediatric Pain Management
Virtual Grand Rounds
After this Virtual Grand Round, participants should be able to: 1) Review the development of pain pathways, 2) Describe factors for complete pain assessment, and 3) Discuss multi-disciplinary chronic pain management. [Recorded 10/13/2023]

Grand Rounds - 10/13/2023 - Pediatric Pain Management

1) Review the development of pain pathways, 2) Describe factors for complete pain assessment, and 3) Discuss multi-disciplinary chronic pain management

Please login or register to take this course.
  • 1.00 AMA PRA Category 1 Credit™
    Nicklaus Children's Hospital designates this Live Activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
    • 1.00 MATE Act Compliant
  • 1.00 Attendance
    Acknowledging attendance at this educational activity.
    • 1.00 Approved for AMA PRA Category 1 Credit™
Subscribe to RSS - DEA MATE Act Compliant